Baicalin-loaded MOF-818 nanozyme for ischemic stroke treatment via ROS scavenging and neuroinflammation suppression
Biomedical Materials · 2026
DOI: 10.1088/1748-605x/ae96ef ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, 2026. Verfasst von Wei Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Flavonoids, Reactive Oxygen Species, Ischemic Stroke, Neuroinflammatory Diseases. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Development Project of the Affiliated Hospital of Shandong Second Medical University, Shandong Province Medical and Health Science and Technology.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke (IS) reperfusion induces neuronal damage through excessive reactive oxygen species (ROS) and neuroinflammation. Baicalin (Bai) shows antioxidant and anti-inflammatory effects but suffers from poor solubility and bioavailability. Metal-organic framework (MOF)-818, a zirconium-based framework with superoxide dismutase- and catalase-mimicking activity, efficiently scavenges ROS but lacks pharmacological versatility. Combining Bai with MOF-818 may offer multitarget neuroprotection in IS. To investigate the therapeutic efficacy and mechanisms of Bai-loaded MOF-818 (Bai@MOF-818) in IS. In vitro oxygen-glucose deprivation/reperfusion models using PC-12 cells and BV-2 microglia were employed to assess ROS scavenging, mitochondrial protection, apoptosis, and microglial polarization. In vivo , Bai@MOF-818 was stereotactically delivered into the ischemic core of rats subjected to transient middle cerebral artery occlusion. Neurological function, infarct volume, oxidative stress, apoptosis, and microglial polarization were evaluated. Bai@MOF-818 markedly scavenged ROS, restored mitochondrial membrane potential, and promoted M1-to-M2 microglial polarization via NF- κ B inhibition and PPAR γ activation. This led to reduced TNF- α /IL-6 and increased IL-10/Arg-1, alleviating neuroinflammation. Furthermore, Bai@MOF-818 inhibited neuronal apoptosis by suppressing Bax and cleaved caspase-3 while elevating the Bcl-2/Bax ratio. Histological analyses revealed preserved tissue integrity, enhanced neuronal survival, reduced infarct size and edema, and improved motor and sensory recovery. Bai@MOF-818 exerts synergistic antioxidant and anti-inflammatory actions, attenuates neuronal apoptosis, and enhances neurological recovery, representing a promising multitarget therapeutic for cerebral ischemia-reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- Department of Neurology, Linyi People's Hospital, Linyi, Shandong, People's Republic of China.
- These authors contributed equally to this work.
- School of Nursing, Jinzhou Medical University, Jinzhou, People's Republic of China.
- Department of Hospital Infection Management, Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong, People's Republic of China.
- Central Laboratory, Linyi People's Hospital, Linyi, Shandong, People's Republic of China.
ORCID-Profile: Wei Shen, Fengyuan Che
Förderung
- National Natural Science Foundation of China
- Science and Technology Development Project of the Affiliated Hospital of Shandong Second Medical University
- Shandong Province Medical and Health Science and Technology
- Natural Science Foundation of Shandong Province
Zitieren
APA
Shen, W., Wang, Y., Zhu, X., Chen, X., Wang, X., & Che, F. (2026). Baicalin-loaded MOF-818 nanozyme for ischemic stroke treatment via ROS scavenging and neuroinflammation suppression. Biomedical Materials. https://doi.org/10.1088/1748-605x/ae96ef
Vancouver
Shen W, Wang Y, Zhu X, Chen X, Wang X, Che F. Baicalin-loaded MOF-818 nanozyme for ischemic stroke treatment via ROS scavenging and neuroinflammation suppression. Biomedical Materials. 2026. doi:10.1088/1748-605x/ae96ef
BibTeX
@article{Shen2026,
author = {Shen, Wei and Wang, YuChen and Zhu, Xiaosong and Chen, Xiaojuan and Wang, Xianjun and Che, Fengyuan},
title = {Baicalin-loaded MOF-818 nanozyme for ischemic stroke treatment via ROS scavenging and neuroinflammation suppression},
journal = {Biomedical Materials},
year = {2026},
doi = {10.1088/1748-605x/ae96ef}
}
EUVIMED